These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22541073)
1. [Suppression of NAMPT expression enhances the sensitivity of K562 cells to imatinib and its relative mechanism]. Lin PP; Bai XJ; Yue ZX; Yan SF; Li ZW; Gao C; Mei YY; Wang KL; Li WJ; Ding W; Li ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):235-41. PubMed ID: 22541073 [TBL] [Abstract][Full Text] [Related]
2. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line]. Wu RJ; Huang YQ; Ma XD Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223 [TBL] [Abstract][Full Text] [Related]
3. Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells. Gottschalk S; Anderson N; Hainz C; Eckhardt SG; Serkova NJ Clin Cancer Res; 2004 Oct; 10(19):6661-8. PubMed ID: 15475456 [TBL] [Abstract][Full Text] [Related]
4. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Wei W; Huang H; Zhao S; Liu W; Liu CX; Chen L; Li JM; Wu YL; Yan H Apoptosis; 2013 Sep; 18(9):1060-70. PubMed ID: 23613107 [TBL] [Abstract][Full Text] [Related]
5. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism]. Shi DX; Ma LM; Lu YJ; Bai B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284 [TBL] [Abstract][Full Text] [Related]
6. Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo. Wei YL; Xu L; Liang Y; Xu XH; Zhao XY Acta Pharmacol Sin; 2009 Apr; 30(4):451-7. PubMed ID: 19270722 [TBL] [Abstract][Full Text] [Related]
7. [STI571 induces apoptosis of K562 cells through down-regulation of anti-apoptotic protein Mcl-1 and Bcl-xl expression]. Zhang BZ; Ren HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1182-5. PubMed ID: 18088462 [TBL] [Abstract][Full Text] [Related]
8. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment. Zhang H; Chang G; Wang J; Lin Y; Ma L; Pang T Leuk Res; 2013 Nov; 37(11):1583-91. PubMed ID: 24125838 [TBL] [Abstract][Full Text] [Related]
9. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells]. Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496 [TBL] [Abstract][Full Text] [Related]
10. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate. Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040 [TBL] [Abstract][Full Text] [Related]
11. Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells. Fiskus W; Pranpat M; Balasis M; Bali P; Estrella V; Kumaraswamy S; Rao R; Rocha K; Herger B; Lee F; Richon V; Bhalla K Clin Cancer Res; 2006 Oct; 12(19):5869-78. PubMed ID: 17020995 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of 4-chlorobenzoyl berbamine on imatinib-resistant K562 cells in vitro and in vivo]. Zhang YF; Xu GB; Gan YC; Xu XH; Xu RZ Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1997-2001. PubMed ID: 22200699 [TBL] [Abstract][Full Text] [Related]
13. [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells]. Chen NY; Wang J; Wang XM; Zhang HX; Yan ZY; Wang YM; Zhang S; Yan B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):882-6. PubMed ID: 20723293 [TBL] [Abstract][Full Text] [Related]
14. NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants. Lounnas N; Frelin C; Gonthier N; Colosetti P; Sirvent A; Cassuto JP; Berthier F; Sirvent N; Rousselot P; Dreano M; Peyron JF; Imbert V Int J Cancer; 2009 Jul; 125(2):308-17. PubMed ID: 19378338 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression. Nakamura S; Yokota D; Tan L; Nagata Y; Takemura T; Hirano I; Shigeno K; Shibata K; Fujisawa S; Ohnishi K Int J Cancer; 2012 Mar; 130(5):1046-59. PubMed ID: 21400515 [TBL] [Abstract][Full Text] [Related]
16. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. Karimiani EG; Marriage F; Merritt AJ; Burthem J; Byers RJ; Day PJ Exp Hematol; 2014 Mar; 42(3):183-191.e5. PubMed ID: 24269846 [TBL] [Abstract][Full Text] [Related]
17. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562]. Wang W; DU Y; Lin GQ; Li NN; Sun BZ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411 [TBL] [Abstract][Full Text] [Related]
18. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells]. Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468 [TBL] [Abstract][Full Text] [Related]
19. [Effect of ZD6474 on the proliferation of imatinib-resistant K562 cells]. Jia HY; Wu XM; Wang ZY; Deng XY; Lin Z; Feng GL; Huang WL Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):371-5. PubMed ID: 21122350 [TBL] [Abstract][Full Text] [Related]
20. [Overexpression of SHP-1 Enhances the Sensitivity of K562 Cells to Imatinib]. Li YH; Liu XD; Guo XF; Liu X; Luo JM; Li ZS; Zhang YX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):46-51. PubMed ID: 26913392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]